GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Di&g Regulatory News (ADIG)

Share Price Information for Abrdn Di&g (ADIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 81.00
Bid: 80.80
Ask: 82.00
Change: -0.10 (-0.12%)
Spread: 1.20 (1.485%)
Open: 81.00
High: 81.00
Low: 81.00
Prev. Close: 81.50
ADIG Live PriceLast checked at -
Aberdeen Diversified Income & Growth is an Investment Trust

To target a total portfolio return of LIBOR (London Interbank Offered Rate) plus 5.5% p.a. (net of fees) over rolling five-year periods through investments from the widest range of asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Redemption of 6.25% Bonds due 2031

10 Apr 2024 07:00

RNS Number : 9100J
abrdn Diversified Income and Growth
10 April 2024
 

abrDn diversified income and growth PLC

Legal Entity Identifier (LEI): 2138003QINEGCHYGW702

10 APRIL 2024

REDEMPTION AND CANCELLATION OF 6.25 PER CENT BONDS DUE 2031

Bond Redemption

The Board of abrdn Diversified Income and Growth plc (the "Company") hereby announces that, following the agreement of shareholders to the proposal to put the Company into managed wind-down, the Company redeemed and cancelled the remaining £16,096,000 in aggregate principal amount of its 6.25% Bonds due 2031 (ISIN XS0134340180) (the "Bonds") on 9 April 2024.

As announced on 8 March 2024, the redemption price was 114.983%. The redemption price having been calculated in accordance with the conditions, using the gross redemption yield of the United Kingdom 6% Treasury Stock due 7 December 2028.

Application has been made for the admission of £16,096,000 in principal amount of the Bonds to the Official List of the United Kingdom Listing Authority to be cancelled in accordance with the FCA's Listing Rules. Following this redemption and cancellation there remain no further Bonds outstanding and the Company has no further debt.

 

Expected circular and approvals

 

The Company has commenced the process required for Court approval for the shareholder approved reduction in the nominal value of the Company's ordinary shares from 25 pence per ordinary share to one penny per ordinary share (the "Capital Reduction") and cancellation of the entire amount standing to the credit of the Company's capital redemption reserve (the "Capital Redemption Cancellation") and share premium account to create distributable reserves which may be applied in any manner permitted by the Companies Act and/or the Company's articles of association (including for any bonus share issues and/or redemptions, tender offers, share buy backs and/or other returns of capital) excluding (in respect of the Capital Reduction and Capital Redemption Cancellation) the payment of dividends.

 

The Company also expects in the coming weeks to issue a further circular providing details of the expected initial capital return, which is proposed to be carried out by way of an issue and redemption of bonus shares to all shareholders (the "B Share Scheme"), including a summary of the UK taxation consequences for shareholders. The circular will convene a general meeting to seek the further shareholder approvals required to be granted for the implementation of the B Share Scheme. Subject to these further shareholder approvals being granted and the required Court approvals being received, it is expected that the initial return of capital will be implemented around the end of June 2024.

 

 

Contact details

For further information please contact:

abrdn Holdings Limited, Secretaries

Email: cef.cosec@abrdn.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSMFIUELSESL
Date   Source Headline
20th Feb 20231:35 pmRNSGearing disclosure
20th Feb 202312:37 pmRNSNet Asset Value(s)
17th Feb 20235:03 pmRNSTransaction in Own Shares
17th Feb 202312:34 pmRNSNet Asset Value(s)
16th Feb 20235:03 pmRNSTransaction in Own Shares
16th Feb 202312:07 pmRNSNet Asset Value(s)
15th Feb 20235:05 pmRNSTransaction in Own Shares
15th Feb 202311:31 amRNSNet Asset Value(s)
14th Feb 20235:19 pmRNSTransaction in Own Shares
14th Feb 20234:06 pmRNSPortfolio disclosure
14th Feb 202312:28 pmRNSNet Asset Value(s)
13th Feb 20233:48 pmRNSGearing disclosure
13th Feb 202312:29 pmRNSNet Asset Value(s)
10th Feb 20234:55 pmRNSTransaction in Own Shares
10th Feb 202312:41 pmRNSNet Asset Value(s)
9th Feb 20235:22 pmRNSTransaction in Own Shares
9th Feb 20231:05 pmRNSNet Asset Value(s)
8th Feb 20235:11 pmRNSTransaction in Own Shares
8th Feb 20231:24 pmRNSNet Asset Value(s)
7th Feb 20235:07 pmRNSTransaction in Own Shares
7th Feb 20231:28 pmRNSNet Asset Value(s)
6th Feb 20234:03 pmRNSMonth End Net Asset Value(s)
6th Feb 20232:42 pmRNSGearing Disclosures
6th Feb 202312:09 pmRNSNet Asset Value(s)
3rd Feb 202312:23 pmRNSNet Asset Value(s)
2nd Feb 20231:00 pmRNSNet Asset Value(s)
1st Feb 202310:30 amRNSTotal Voting Rights
31st Jan 202312:33 pmRNSNet Asset Value(s)
30th Jan 20235:16 pmRNSTransaction in Own Shares
30th Jan 20232:10 pmRNSGearing disclosure
30th Jan 202312:31 pmRNSNet Asset Value(s)
27th Jan 20235:03 pmRNSTransaction in Own Shares
27th Jan 202312:09 pmRNSNet Asset Value(s)
26th Jan 20235:05 pmRNSTransaction in Own Shares
26th Jan 202312:00 pmRNSNet Asset Value(s)
25th Jan 20235:06 pmRNSTransaction in Own Shares
25th Jan 202312:31 pmRNSNet Asset Value(s)
24th Jan 20234:59 pmRNSTransaction in Own Shares
24th Jan 202312:58 pmRNSNet Asset Value(s)
24th Jan 202311:19 amRNSDoc re. Annual Financial Report
23rd Jan 20235:37 pmRNSTransaction in Own Shares
23rd Jan 20234:22 pmRNSGearing disclosure
23rd Jan 202312:35 pmRNSNet Asset Value(s)
20th Jan 20235:05 pmRNSTransaction in Own Shares
20th Jan 20232:04 pmRNSDirector/PDMR Shareholding
20th Jan 202312:48 pmRNSNet Asset Value(s)
19th Jan 20235:04 pmRNSTransaction in Own Shares
19th Jan 202312:42 pmRNSNet Asset Value(s)
18th Jan 20235:17 pmRNSTransaction in Own Shares
18th Jan 20235:10 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.